Home › Funds › Integral Health Asset Management, LLC › VRTX
Integral Health Asset Management, LLC position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
Integral Health Asset Management, LLC reported holding 40,000 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$19.9M, representing 0.89% of its reported portfolio and ranking #36 among its reported holdings. Integral Health Asset Management, LLC has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Integral Health Asset Management, LLC's VRTX position evolved
Integral Health Asset Management, LLC first disclosed a stake in VRTX in Q1 2026 at 40,000 shares (US$17.9M). The position peaked in Q2 2026 at 40,000 shares, worth US$19.9M. Across 2 filings, Integral Health Asset Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 40,000 shares valued at US$19.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 40.00K | $17.86M | New |
| Q2 2026 | 40.00K | $19.87M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VRTX and 13F data
VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- LOOMIS SAYLES & CO L P 3.92M sh · $1.95B · Q2 2026
- JENNISON ASSOCIATES LLC 3.00M sh · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M sh · $1.35B · Q2 2026
- Clearbridge Investments, LLC 2.34M sh · $1.16B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.17M sh · $1.08B · Q2 2026
- Janus Henderson Group 2.13M sh · $951.79M · Q1 2026
More on Integral Health Asset Management, LLC
FAQ
How long has Integral Health Asset Management, LLC held VRTX?
Integral Health Asset Management, LLC has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Integral Health Asset Management, LLC's current position in VRTX?
As of Q2 2026, Integral Health Asset Management, LLC holds 40.00K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $19.87M, representing 0.89% of its reported portfolio and ranking #36.
Has Integral Health Asset Management, LLC been buying or selling VRTX?
In the latest 13F filing (Q2 2026), Integral Health Asset Management, LLC held unchanged its position in VRTX. The position peaked in Q2 2026 at 40.00K shares.
Which other funds hold VRTX?
Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.